Human Genome Epidemiology Literature Finder
Records 1 - 18 (of 18 Records) |
Query Trace: BOC[original query] |
---|
ITPA and SLC29A1 Genotyping for the Prediction of Ribavirin Dose Reduction in Anti-HCV Triple Therapy with Protease Inhibitors. Pharmacology 2015 96 (3-4): 163-6. Lombardi Andrea, Landonio Simona, Magni Carlo, Cheli Stefania, Mazzali Cristina, Mondelli Mario U, Rizzardini Giuliano, Clementi Emilio, Falvella Felicia Stefan |
Intracellular accumulation of boceprevir according to plasma concentrations and pharmacogenetics. International journal of antimicrobial agents 2015 Jun 45 (6): 657-61. Cusato Jessica, Allegra Sarah, De Nicolò Amedeo, Boglione Lucio, Fatiguso Giovanna, Abdi Adnan Mohamed, Cariti Giuseppe, Di Perri Giovanni, D'Avolio Anton |
Triple therapy with boceprevir or telaprevir in a European cohort of cirrhotic HIV/HCV genotype 1-coinfected patients. Liver international : official journal of the International Association for the Study of the Liver 2015 Sep 35 (9): 2090-9. Miailhes Patrick, Gilbert Camille, Lacombe Karine, Arends Joop E, Puoti Massimo, Rockstroh Jürgen K, Sogni Philippe, Fontaine Hélène, Rosenthal Eric, Winnock Maria, Loko Marc-Arthur, Wittkop Linda, Dabis François, Salmon Dominique, |
Impact of IL28B, APOH and ITPA Polymorphisms on Efficacy and Safety of TVR- or BOC-Based Triple Therapy in Treatment-Experienced HCV-1 Patients with Compensated Cirrhosis from the ANRS CO20-CUPIC Study. PloS one 2015 10 (12): e0145105. About Frédégonde, Oudot-Mellakh Tiphaine, Niay Jonathan, Rabiéga Pascaline, Pedergnana Vincent, Duffy Darragh, Sultanik Philippe, Cagnot Carole, Carrat Fabrice, Marcellin Patrick, Zoulim Fabien, Larrey Dominique, Hézode Christophe, Fontaine Hélène, Bronowicki Jean-Pierre, Pol Stanislas, Albert Matthew L, Theodorou Ioannis, Cobat Aurélie, Abel Laurent, |
ITPA deficiency and ribavirin level are still predictive of anaemia in HCV-HIV-coinfected patients receiving ribavirin combined with a first-generation DAA (ANRS HC27 study). Antiviral therapy 2016 Sep . Kheloufi Farid, Poizot-Martin Isabelle, Garraffo Rodolphe, Tavenard Aude, Quaranta Sylvie, Renault Alain, Lavrut Thibault, Bourlière Marc, Halfon Philippe, Piroth Lionel, Bellissant Eric, Lacarelle Bruno, Molina Jean-Michel, Solas Caroline, , Group Boceprevih Stu |
Spectrum of BRCA1/2 variants in 940 patients from Argentina including novel, deleterious and recurrent germline mutations: impact on healthcare and clinical practice. Oncotarget 2016 (36): 60487-60495. Solano Angela Rosaria, Cardoso Florencia Cecilia, Romano Vanesa, Perazzo Florencia, Bas Carlos, Recondo Gonzalo, Santillan Francisco Bernardo, Gonzalez Eduardo, Abalo Eduardo, Viniegra María, Michel José Davalos, Nuñez Lina María, Noblia Cristina Maria, Mc Lean Ignacio, Canton Enrique Diaz, Chacon Reinaldo Daniel, Cortese Gustavo, Varela Eduardo Beccar, Greco Martín, Barrientos María Laura, Avila Silvia Adela, Vuotto Hector Daniel, Lorusso Antonio, Podesta Ernesto Jorge, Mando Oscar Gasp |
Addition of boceprevir to PEG-interferon/ribavirin in HIV-HCV-Genotype-1-coinfected, treatment-experienced patients: efficacy, safety, and pharmacokinetics data from the ANRS HC27 study. HIV clinical trials 2016 Mar 17 (2): 63-71. Poizot-Martin Isabelle, Bellissant Eric, Garraffo Rodolphe, Colson Philippe, Piroth Lionel, Solas Caroline, Renault Alain, Bourlière Marc, Halfon Philippe, Ghosn Jade, Alric Laurent, Naqvi Alissa, Carrieri Patrizia, Molina Jean-Michel, |
Prevalence of BRAF, NRAS and c-KIT mutations in Slovenian patients with advanced melanoma. Radiology and oncology 2018 Apr 52 (3): 289-295. Moltara Maja Ebert, Novakovic Srdjan, Boc Marko, Bucic Marina, Rebersek Martina, Zadnik Vesna, Ocvirk Jan |
The effect of the first-generation HCV-protease inhibitors boceprevir and telaprevir and the relation to baseline NS3 resistance mutations in genotype 1: experience from a small Swedish cohort. Upsala journal of medical sciences 2018 3 123 (1): 50-56. Kjellin Midori, Wesslén Terése, Löfblad Erik, Lennerstrand Johan, Lannergård Ande |
The efficacy of paritaprevir/ritonavir/ombitasvir+dasabuvir and ledipasvir/sofosbuvir is comparable in patients who failed interferon-based treatment with first generation protease inhibitors - a multicenter cohort study. BMC infectious diseases 2018 11 18 (1): 580. Janczewska Ewa, Zar?bska-Michaluk Dorota, Berak Hanna, Piekarska Anna, Gietka Andrzej, Dybowska Dorota, Mazur W?odzimierz, Belica-Wdowik Teresa, Dobracki Witold, Tudrujek-Zdunek Magdalena, Dero? Zbigniew, Buczy?ska Iwona, Sitko Marek, Czau?-Andrzejuk Agnieszka, Lorenc Beata, Bia?kowska-Warzecha Jolanta, Citko Jolanta, Laurans ?ukasz, Jaroszewicz Jerzy, Socha ?ukasz, Tronina Olga, Adamek Brygida, Horban Andrzej, Halota Waldemar, Baka-?wierz Barbara, Tomasiewicz Krzysztof, Simon Krzysztof, Garlicki Aleksander, Wawrzynowicz-Syczewska Marta, Flisiak Robe |
Molecular biomarkers and histological parameters impact on survival and response to first- line systemic therapy of metastatic colorectal cancer patients. Radiology and oncology 2019 Mar 53 (1): 85-95. Rebersek Martina, Mesti Tanja, Boc Marko, Ocvirk Jan |
Paraoxonase-1 Serum Concentration and PON1 Gene Polymorphisms: Relationship with Non-Alcoholic Fatty Liver Disease. Journal of clinical medicine 2019 12 8 (12): . Milaciu Mircea Vasile, Vesa ?tefan Cristian, Boc?an Ioana Corina, Cium?rnean Lorena, Sâmpelean Dorel, Negrean Vasile, Pop Raluca Maria, Matei Daniela Maria, Pa?ca Sergiu, R?chi?an Andreea Liana, Buzoianu Anca Dana, Acalovschi Moni |
Study of the Genetic Variants in BRCA1/2 and Non-BRCA Genes in a Population-Based Cohort of 2155 Breast/Ovary Cancer Patients, Including 443 Triple-Negative Breast Cancer Patients, in Argentina. Cancers 2021 May 13 (11): . Solano Angela R, Mele Pablo G, Jalil Fernanda S, Liria Natalia C, Podesta Ernesto J, Gutiérrez Leandro |
Female-Specific Susceptibility Locus in BOC and SEC16B are Associated with Adolescent Idiopathic Scoliosis. Spine 2021 5 46 (22): E1178-E1184. Dai Zhicheng, Wang Yuwen, Wu Zhichong, Feng Zhenhua, Sun Xu, Qiu Yong, Cheng Jack Chun-Yiu, Xu Leilei, Zhu Zezha |
Polymorphism of formyl peptide receptor 1 (FPR1) reduces the therapeutic efficiency and antitumor immunity after neoadjuvant chemoradiotherapy (CCRT) treatment in locally advanced rectal cancer. Cancer immunology, immunotherapy : CII 2021 3 70 (10): 2937-2950. Chiang Shu-Fen, Huang Kevin Chih-Yang, Chen William Tzu-Liang, Chen Tsung-Wei, Ke Tao-Wei, Chao K S Cliffo |
PALB2 germline mutations in a multi-gene panel testing cohort of 1905 breast-ovarian cancer patients in Argentina. Breast cancer research and treatment 2022 May . Gonzalez Ariana, Del Greco Franco, Vargas-Roig Laura, Brun Bianca, Tabares Gonzalo, Mampel Alejandra, Montes Cecilia, Martin Claudia, Lopez Marcela, Rossi Norma, Bruno Luisina, Ponce Carolina, Quaglio Patricia, Yanzi Alvaro, Acevedo Santiago, Lugo Lilia, Lopez Breccia Paula, Avila Silvia, Sisterna Silvina, Del Castillo María Soledad, Vazquez Martín, Nuñez Lina |
Validation and Data-Integration of Yeast-Based Assays for Functional Classification of BRCA1 Missense Variants. International journal of molecular sciences 2022 4 23 (7): . Bellè Francesca, Mercatanti Alberto, Lodovichi Samuele, Congregati Caterina, Guglielmi Chiara, Tancredi Mariella, Caligo Maria Adelaide, Cervelli Tiziana, Galli Alva |
Prognostic Factors for Restenosis of Superficial Femoral Artery after Endovascular Treatment. Journal of clinical medicine 2023 10 12 (19): . Vinko Boc, Matija Kozak, Barbara Eržen, Mojca Boži? Mijovski, Anja Boc, Aleš Bli |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: